When IFs are unintentionally identified, these results should only be disclosed if they are highly significant, highly penetrant and medically actionable [ 17 – 19 ].
← all excerpts
Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.
1
—
—